
Zion Biotechnologies Private Limited
About Zion Biotechnologies Private Limited
Data last updated:
Zion Biotechnologies Private Limited is a private limited company based in Delhi, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 12 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC143538.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pravesh Sahni and Jayant Malhotra.
Its last annual general meeting (AGM) was held on 05 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at M – 165 Greater Kailash Part – 2, Delhi, India – 110048.
As per the financials filed for FY 2026, the company reported a revenue of ₹41,328, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹7,933 (net margin 19.2%) and EBITDA of ₹10,603 (EBITDA margin 25.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zion Biotechnologies Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 165 Greater Kailash Part – 2, Delhi, India – 110048
- IndustryLife Sciences, Biotechnology
To see the full contact details of Zion Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zion Biotechnologies Private Limited
FY 2026 filings availableZion Biotechnologies Private Limited reported revenue of ₹41,328 (down 7% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹41,328 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,603 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,933 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.7% | ||||
| Net Profit Margin | 19.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zion Biotechnologies Private Limited, buy the company report.
Board of directors of Zion Biotechnologies Private Limited
Zion Biotechnologies has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravesh Sahni | Director | 01 Mar 2007 | 19 Years 8 Months | Current |
| Jayant Malhotra Also directs: Malhotra Finvest Private Limited, Pal Jay Power Solutions Private Limited, Pal Svam Power Solutions Private Limited and 5 more | Director | 01 Mar 2007 | 19 Years 8 Months | Current |
Peer comparison
Zion Biotechnologies Private Limited is compared with the 5 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Evolva Biotech Private Limited | ₹57,246 (FY 2020) | -98.0% | Chennai, Tamil Nadu, India | |||
| Jubilant Innovation (India) Limited | ₹49,000 (FY 2018) | -66.0% | Noida, Uttar Pradesh, India | |||
| Genophe Biotech Private Limited | ₹44,240 (FY 2024) | -97.0% | Bangalore, Karnataka, India | |||
| Aeka Biochemicals Private Limited | ₹42,373 (FY 2024) | -92.0% | Thiruvananthapuram, Kerala, India | |||
| Mabtree Biologics India Private Limited | ₹41,511 (FY 2023) | -96.0% | Hyderabad, Telangana, India | |||
| Zion Biotechnologies Private Limitedthis company | ₹41,328 (FY 2026) | ₹7,933 | 19.2% | -7.0% | Delhi, India |
To see the full peer comparison of Zion Biotechnologies Private Limited, buy the company report.
Auditor
Zion Biotechnologies Private Limited is audited by GOPAL CHOPRA AND ASSOCIATES for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOPAL CHOPRA AND ASSOCIATES | FY 2026 | 010578N |
Shareholding
The shareholding of Zion Biotechnologies Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zion Biotechnologies Private Limited, buy the company report.
Legal cases
Zion Biotechnologies Private Limited has 4 court cases on record: 4 filed by Zion Biotechnologies. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
| High courts | 2 | 0 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Criminal case | Filed by the company against Assotech Limited | Pending |
| High Court of Delhi | Court case (O.M.P.(I)) | Filed by the company against Assotech Limited & Anr. | Disposed |
| High Court of Delhi | Court case (CONT.CAS(C)) | Filed by the company against an individual | Pending |
To see the full case history of Zion Biotechnologies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zion Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zion Biotechnologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zion Biotechnologies Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Pradeep Seth ceased to be Director on 10 Mar 2007.
Frequently asked questions
Zion Biotechnologies is an active private limited company based in Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 12 December 2005 (21+ years old) and is registered under CIN U24232DL2005PTC143538.
Zion Biotechnologies has 2 current directors:
- Pravesh Sahni - Director
- Jayant Malhotra - Director
The latest financial statements of Zion Biotechnologies on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 05 August 2026. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Zion Biotechnologies is U24232DL2005PTC143538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zion Biotechnologies has 4 court cases on record: 4 filed by the company. 3 are pending. Most are in the district courts.
Zion Biotechnologies was incorporated on 12 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Zion Biotechnologies by revenue are Evolva Biotech Private Limited, Jubilant Innovation (India) Limited, Genophe Biotech Private Limited, Aeka Biochemicals Private Limited, Mabtree Biologics India Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (other professional, scientific and technical activities).
Pradeep Seth ceased to be Director on 10 Mar 2007. Punam Seth ceased to be Director on 10 Mar 2007. Jayant Malhotra was appointed as Director on 01 Mar 2007. Zion Biotechnologies has 4 board changes on record in total.
The registered office of Zion Biotechnologies is at M – 165 Greater Kailash Part – 2, Delhi, India – 110048.
Zion Biotechnologies operates in the life sciences industry, in the biotechnology segment.
The compliance status of Zion Biotechnologies is compliant as of 11 November 2026. The company is actively filing with the Registrar of Companies.

